Vicente
Vicente Garcia
Profesor Emerito
Hospital del Mar
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital del Mar (15)
2024
-
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study
The Lancet Haematology, Vol. 11, Núm. 8, pp. e606-e616
2023
2022
-
Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry
Biomedicines, Vol. 10, Núm. 1
2021
-
High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome
American Journal of Hematology, Vol. 96, Núm. 11, pp. 1363-1373
2016
-
Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method
Annals of Hematology, Vol. 95, Núm. 5, pp. 719-732
-
Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines
Annals of Hematology, Vol. 95, Núm. 7, pp. 1089-1098
2013
-
Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: Clonal evolution and hierarchy revealed by next-generation sequencing
Journal of Hematology and Oncology, Vol. 6, Núm. 1
2012
2010
-
Antithrombin Murcia (K241E) causing antithrombin deficiency: A possible role for altered glycosylation
Haematologica, Vol. 95, Núm. 8, pp. 1358-1365
-
Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody
Thrombosis and Haemostasis, Vol. 104, Núm. 6, pp. 1143-1149
-
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
Blood, Vol. 116, Núm. 8, pp. 1205-1210
2009
-
ABO blood group does not increase the risk of thrombosis in Philadelphia-negative myeloproliferative disorders
Blood Coagulation and Fibrinolysis
-
Análisis retrospectivo de la eficacia y la tolerabilidad de anagrelida en pacientes con trombocitemia esencial: Registro español de trombocitemia esencial
Medicina Clinica, Vol. 133, Núm. 3, pp. 86-90
2008
-
JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia
Annals of Hematology
-
Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury
Critical Care Medicine, Vol. 36, Núm. 2, pp. 526-534